Your search for: "" revealed the following:

Search...

Teléfono: (+5982) 1704

Email: info@lablibra.com

Vigilancia Sanitaria
  • Español
  • Home
  • Lab Libra
    • About us
    • History
    • Where we are
    • Our business premises
    • Capacity & Technology
    • Environment
    • Human resources
    • Companies that trust us
  • Products
    • Specialties
    • Therapeutic Categories
    • Active Substance
    • Alphabetical Order
  • Libra worldwide
  • Libra Chile
  • News
  • Events
  • Contact us
Laboratorio Libra
Laboratorio Libra
  • Home
  • Lab Libra
    • About us
    • History
    • Where we are
    • Our business premises
    • Capacity & Technology
    • Environment
    • Human resources
    • Companies that trust us
  • Products
    • Specialties
    • Therapeutic Categories
    • Active Substance
    • Alphabetical Order
  • Libra worldwide
  • Libra Chile
  • News
  • Events
  • Contact us

Footer Templates

HomeFooter Templates
Laboratorio Libra
Laboratorio Libra
  • Home
  • Lab Libra
    • About us
    • History
    • Where we are
    • Our business premises
    • Capacity & Technology
    • Environment
    • Human resources
    • Companies that trust us
  • Products
    • Specialties
    • Therapeutic Categories
    • Active Substance
    • Alphabetical Order
  • Libra worldwide
  • Libra Chile
  • News
  • Events
  • Contact us

Your search for: "" revealed the following:

Search...

Footer Templates

HomeFooter Templates

Footer eng

Welcome to Laboratorio LIBRA, a dynamic Uruguayan company whith a responsible and committed relationship with health professionals and users.

News

GMP certificate renewal

New release: Ácido micofenólico EMS

New release: LENALIDOMIDA LIBRA

New effluent treatment plant

Map

Contact us

Offices:
Solferino 4096 – C.P. 11400
Planta Industrial:
Arroyo Grande 2832 – C.P. 11800
Centro Logístico:
Camino Carrasco 5119 – C.P. 13000
Phone: (+5982) 1704
Email: info@lablibra.com

© Copyright 2019. Laboratorio Libra – All rights reserved

adminLabLibadminLabLib
November 10, 2020
0
Share: